Matthew Arnold

Most Recent Articles by Matthew Arnold

Top 100 Agencies: CDM New York

Top 100 Agencies: CDM New York

This "strong, steady and stable" ­agency has designs on innovation

Top 100 Agencies: CDM Princeton

Top 100 Agencies: CDM Princeton

Relying on a collaborative culture to push a new surge in business

Top 100 Agencies: CDMiConnect

Top 100 Agencies: CDMiConnect

Ahead of the pack in digital, and doubling down on patient marketing

Top 100 Agencies: H4B Catapult

Top 100 Agencies: H4B Catapult

Havas shop grows a diversifying business from its digital roots

Top 100 Agencies: H4B Chelsea

Top 100 Agencies: H4B Chelsea

An "all-in-one" agency succeeds by having an all-for-one corporate spirit

More Articles by Matthew Arnold


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.